This observational study aims to find better ways to detect and prevent ovarian cancer early, especially for women at high risk. Researchers are collecting blood samples (to test for biomarkers like CA-125), tissue, and other body fluids to develop new markers for early detection. They are also using questionnaires to understand the quality of life for women at increased risk or diagnosed with ovarian cancer. You may be eligible if you are a woman between 18 and 80 years old and have a higher risk of ovarian cancer, such as having close relatives with ovarian, primary peritoneal, or fallopian tube cancer. The main goal is to develop better ultrasound and blood tests for ovarian cancer detection and management, with results measured at 1 year. The current status of this study is unclear.

Study design

This is an observational study with a planned enrollment of 6000 women. It is not specified if it is randomized or blinded.

What's involved

Participants will provide periodic specimens (blood, tissue, or body fluids) and data. They may also complete questionnaires about their psychological functioning.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoints for developing detection methods are measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.